These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9920146)

  • 21. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial plasma lipoprotein changes in human subjects of different ages.
    Cohn JS; McNamara JR; Cohn SD; Ordovas JM; Schaefer EJ
    J Lipid Res; 1988 Apr; 29(4):469-79. PubMed ID: 3392464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
    Newnham HH; Barter PJ
    Biochim Biophys Acta; 1992 May; 1125(3):297-304. PubMed ID: 1596518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
    Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.
    Cohn JS; McNamara JR; Cohn SD; Ordovas JM; Schaefer EJ
    J Lipid Res; 1988 Jul; 29(7):925-36. PubMed ID: 3411251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states.
    Lottenberg AM; Nunes VS; Lottenberg SA; Shimabukuro AF; Carrilho AJ; Malagutti S; Nakandakare ER; McPherson R; Quintão EC
    Atherosclerosis; 1996 Oct; 126(2):265-75. PubMed ID: 8902152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.
    Qin S; Kawano K; Bruce C; Lin M; Bisgaier C; Tall AR; Jiang X
    J Lipid Res; 2000 Feb; 41(2):269-76. PubMed ID: 10681411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations.
    Kosuge K; Miida T; Takahashi A; Obayashi K; Ito M; Ito T; Soda S; Ozaki K; Hirayama S; Hanyu O; Aizawa Y; Nakamura Y
    Atherosclerosis; 2006 Feb; 184(2):413-9. PubMed ID: 16024022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.